180 related articles for article (PubMed ID: 24276835)
1. Features and outcomes of patients who underwent cardiac device deactivation.
Buchhalter LC; Ottenberg AL; Webster TL; Swetz KM; Hayes DL; Mueller PS
JAMA Intern Med; 2014 Jan; 174(1):80-5. PubMed ID: 24276835
[TBL] [Abstract][Full Text] [Related]
2. The ethics of unilateral implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillator deactivation: patient perspectives.
Daeschler M; Verdino RJ; Kirkpatrick JN
Europace; 2017 Aug; 19(8):1343-1348. PubMed ID: 27915265
[TBL] [Abstract][Full Text] [Related]
3. Palliative Care Consultation and Associated End-of-Life Care After Pacemaker or Implantable Cardioverter-Defibrillator Deactivation.
Pasalic D; Gazelka HM; Topazian RJ; Buchhalter LC; Ottenberg AL; Webster TL; Swetz KM; Mueller PS
Am J Hosp Palliat Care; 2016 Dec; 33(10):966-971. PubMed ID: 26169518
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; van Bruchem-Visser RL; Theuns DA; Bhagwandien RE; Van der Heide A; Rietjens JA
Heart; 2020 Feb; 106(3):190-195. PubMed ID: 31537636
[TBL] [Abstract][Full Text] [Related]
5. Deactivation of Implantable Cardioverter Defibrillator in Patients With Terminal Diagnoses.
Trussler A; Alexander B; Campbell D; Alhammad N; Enriquez A; Chacko S; Garrett T; Simpson C; Redfearn D; Abdollah H; Herx L; Baranchuk A
Am J Cardiol; 2019 Oct; 124(7):1064-1068. PubMed ID: 31353003
[TBL] [Abstract][Full Text] [Related]
6. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life.
Mueller PS; Hook CC; Hayes DL
Mayo Clin Proc; 2003 Aug; 78(8):959-63. PubMed ID: 12911044
[TBL] [Abstract][Full Text] [Related]
7. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.
Kramer DB; Kesselheim AS; Salberg L; Brock DW; Maisel WH
Am J Cardiol; 2011 Apr; 107(7):1071-1075.e5. PubMed ID: 21296323
[TBL] [Abstract][Full Text] [Related]
8. Quality dying: An approach to ICD deactivation in the hospital setting.
Turner S; Torabi S; Stilos K
Am J Hosp Palliat Care; 2020 Sep; 37(9):664-668. PubMed ID: 32126793
[TBL] [Abstract][Full Text] [Related]
9. Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life.
Gura MT
AACN Adv Crit Care; 2015; 26(4):356-63. PubMed ID: 26484996
[TBL] [Abstract][Full Text] [Related]
10. [Device therapy in cardiological palliative care situations].
Dutzmann J; Israel CW
Herzschrittmacherther Elektrophysiol; 2019 Jun; 30(2):204-211. PubMed ID: 31049654
[TBL] [Abstract][Full Text] [Related]
11. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.
Kirkpatrick JN; Gottlieb M; Sehgal P; Patel R; Verdino RJ
Am J Cardiol; 2012 Jan; 109(1):91-4. PubMed ID: 21943937
[TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
[TBL] [Abstract][Full Text] [Related]
13. Patients' perception of implantable cardioverter defibrillator deactivation at the end of life.
Hill L; McIlfatrick S; Taylor B; Dixon L; Harbinson M; Fitzsimons D
Palliat Med; 2015 Apr; 29(4):310-23. PubMed ID: 25239128
[TBL] [Abstract][Full Text] [Related]
14. Advance care planning and end-of-life care in patients with an implantable cardioverter defibrillator: The perspective of relatives.
Stoevelaar R; Stoppelenburg A; van Bruchem-Visser RL; van Driel AG; Theuns DA; Lokker ME; Bhagwandien RE; Heide AV; Rietjens JA
Palliat Med; 2021 May; 35(5):904-915. PubMed ID: 33845683
[TBL] [Abstract][Full Text] [Related]
15. Trends in time in the management of the implantable cardioverter defibrillator in the last phase of life: a retrospective study of medical records.
Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; Theuns DA; Bhagwandien RE; van Bruchem-Visser RL; Lokker IE; van der Heide A; Rietjens JA
Eur J Cardiovasc Nurs; 2019 Aug; 18(6):449-457. PubMed ID: 30995145
[TBL] [Abstract][Full Text] [Related]
16. Improving guideline-mandated care of patients with implantable cardiac defibrillators.
Garner D; Blackburn M; Wright DJ; Rao A
Br J Hosp Med (Lond); 2020 Aug; 81(8):1-10. PubMed ID: 32845764
[TBL] [Abstract][Full Text] [Related]
17. Cardiac Implantable Electronic Device Therapy: Permanent Pacemakers, Implantable Cardioverter Defibrillators, and Cardiac Resynchronization Devices.
Steffen MM; Osborn JS; Cutler MJ
Med Clin North Am; 2019 Sep; 103(5):931-943. PubMed ID: 31378335
[TBL] [Abstract][Full Text] [Related]
18. Improving Communication in Heart Failure Patient Care.
Goldstein NE; Mather H; McKendrick K; Gelfman LP; Hutchinson MD; Lampert R; Lipman HI; Matlock DD; Strand JJ; Swetz KM; Kalman J; Kutner JS; Pinney S; Morrison RS
J Am Coll Cardiol; 2019 Oct; 74(13):1682-1692. PubMed ID: 31558252
[TBL] [Abstract][Full Text] [Related]
19. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes.
Mueller PS; Jenkins SM; Bramstedt KA; Hayes DL
Pacing Clin Electrophysiol; 2008 May; 31(5):560-8. PubMed ID: 18439169
[TBL] [Abstract][Full Text] [Related]
20. Deactivation of pacemakers and implantable cardioverter-defibrillators.
Kramer DB; Mitchell SL; Brock DW
Prog Cardiovasc Dis; 2012; 55(3):290-9. PubMed ID: 23217433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
